Showing results (371-380 of 400) with videos related to

Sort By:
Pageof 40
Plos One|October 15, 2015
A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic HistopathologyR Brian Stevens, Kirk W Foster, Clifford D Miles, et al.
Plant Disease|May 5, 2025
Development of a translation elongation factor 1-alpha (TEF) based TaqMan qPCR assay for Diaporthe humulicola, the causal agent of halo blight of hopRoss Joaquin Hatlen, Shay Szymanski, Nanci Adair, et al.
Emerging Infectious Diseases|November 21, 1997
Quantitative microbiology: a basis for food safetyT A McMeekin, J Brown, K Krist, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2021
A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysisA Brufsky, S B Kim, Ž Zvirbule, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 1999
A phase I single-dose trial of gadolinium texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imagingD I Rosenthal, P Nurenberg, C R Becerra, et al.
Plos One|November 25, 2010
Osteopontin is required for the early onset of high fat diet-induced insulin resistance in miceJustin Chapman, Philip D Miles, Jachelle M Ofrecio, et al.
Angewandte Chemie (International Ed. in English)|June 24, 2018
Total Synthesis Establishes the Biosynthetic Pathway to the Naphterpin and Marinone Natural ProductsLauren A M Murray, Shaun M K McKinnie, Henry P Pepper, et al.
British Journal of Cancer|May 17, 2014
Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancerD K Woolf, M Beresford, S P Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2019
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)T Bachelot, E Ciruelos, A Schneeweiss, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 3, 2020
The impact of multi-organ transplant allocation priority on waitlisted kidney transplant candidatesScott G Westphal, Eric D Langewisch, Amanda M Robinson, et al.
Pageof 40